26 results on '"Vascular endothelium -- Genetic aspects"'
Search Results
2. RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity
- Author
-
Kawasaki, Jun, Aegerter, Sandrine, Fevurly, R. Dawn, Mammoto, Akiko, Mammoto, Tadanori, Sahin, Mustafa, Mably, John D., Fishman, Steven J., and Chan, Joanne
- Subjects
Gene mutations -- Identification and classification ,Vascular endothelium -- Genetic aspects ,Cellular signal transduction -- Genetic aspects ,Health care industry - Abstract
Vascular malformations are linked to mutations in RAS p21 protein activator 1 (RASA1, also known as p120RasGAP); however, due to the global expression of this gene, it is unclear how these mutations specifically affect the vasculature. Here, we tested the hypothesis that RASA1 performs a critical effector function downstream of the endothelial receptor EPHB4. In zebrafish models, we found that either RASA1 or EPHB4 deficiency induced strikingly similar abnormalities in blood vessel formation and function. Expression of WT EPHB4 receptor or engineered receptors with altered RASA1 binding revealed that the ability of EPHB4 to recruit RASA1 is required to restore blood flow in EPHB4-deficient animals. Analysis of EPHB4-deficient zebrafish tissue lysates revealed that mTORC1 is robustly overactivated, and pharmacological inhibition of mTORC1 in these animals rescued both vessel structure and function. Furthermore, overexpression of mTORC1 in endothelial cells exacerbated vascular phenotypes in animals with reduced EPHB4 or RASA1, suggesting a functional EPHB4/ RASA1/mTORC1 signaling axis in endothelial cells. Tissue samples from patients with arteriovenous malformations displayed strong endothelial phospho-S6 staining, indicating increased mTORC1 activity. These results indicate that deregulation of EPHB4/RASA1/mTORC1 signaling in endothelial cells promotes vascular malformation and suggest that mTORC1 inhibitors, many of which are approved for the treatment of certain cancers, should be further explored as a potential strategy to treat patients with vascular malformations., Introduction Vascular anomalies encompass a large number of blood and lymphatic vessel disorders that are typically diagnosed during childhood or sometimes by routine prenatal ultrasound screening (1). These primary vascular [...]
- Published
- 2014
- Full Text
- View/download PDF
3. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury
- Author
-
Kapitsinou, Pinelopi P., Sano, Hideto, Michael, Mark, Kobayashi, Hanako, Davidoff, Olena, Bian, Aihua, Yao, Bing, Zhang, Ming-Zhi, Harris, Raymond C., Duffy, Kevin J., Erickson-Miller, Connie L., Sutton, Timothy A., and Haase, Volker H.
- Subjects
Vascular endothelium -- Genetic aspects ,Gene mutations -- Physiological aspects ,Kidneys -- Injuries -- Genetic aspects ,Biological control systems -- Genetic aspects ,Health care industry - Abstract
The hypoxia-inducible transcription factors HIF-1 and HIF-2 mediate key cellular adaptions to hypoxia and contribute to renal homeostasis and pathophysiology; however, little is known about the cell type-specific functions of HIF-1 and HIF-2 in response to ischemic kidney injury. Here, we used a genetic approach to specifically dissect the roles of endothelial HIF-1 and HIF-2 in murine models of hypoxic kidney injury induced by ischemia reperfusion or ureteral obstruction. In both models, inactivation of endothelial HIF increased injury-associated renal inflammation and fibrosis. Specifically, inactivation of endothelial HIF-2α, but not endothelial HIF-1α, resulted in increased expression of renal injury markers and inflammatory cell infiltration in the postischemic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4 (VLA4) using monoclonal antibodies. In contrast, pharmacologic or genetic activation of HIF via HIF prolyl-hydroxylase inhibition protected wild-type animals from ischemic kidney injury and inflammation; however, these same protective effects were not observed in HIF prolyl-hydroxylase inhibitor-treated animals lacking endothelial HIF-2. Taken together, our data indicate that endothelial HIF-2 protects from hypoxia-induced renal damage and represents a potential therapeutic target for renoprotection and prevention of fibrosis following acute ischemic injury., Introduction ECs play a critical role in the pathophysiology of acute and chronic ischemic injuries, as they are involved in the regulation of vascular tone, trafficking of inflammatory cells, delivery [...]
- Published
- 2014
- Full Text
- View/download PDF
4. Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction
- Author
-
Wang, Liming, Yin, Jun, Nickles, Hannah T., Ranke, Hannes, Tabuchi, Arata, Hoffmann, Julia, Tabeling, Christoph, Barbosa-Sicard, Eduardo, Chanson, Marc, Kwak, Brenda R., Shin, Hee-Sup, Wu, Songwei, Isakson, Brant E., Witzenrath, Martin, de Wit, Cor, Fleming, Ingrid, Kuppe, Hermann, and Kuebler, Wolfgang M.
- Subjects
Vascular endothelium -- Genetic aspects ,Vasoconstriction -- Genetic aspects ,Cellular signal transduction -- Genetic aspects ,Hypoxia -- Genetic aspects -- Care and treatment ,Health care industry - Abstract
Hypoxic pulmonary vasoconstriction (HPV) is a physiological mechanism by which pulmonary arteries constrict in hypoxic lung areas in order to redirect blood flow to areas with greater oxygen supply. Both oxygen sensing and the contractile response are thought to be intrinsic to pulmonary arterial smooth muscle cells. Here we speculated that the ideal site for oxygen sensing might instead be at the alveolocapillary level, with subsequent retrograde propagation to upstream arterioles via connexin 40 (Cx40) endothelial gap junctions. HPV was largely attenuated by Cx40-specific and nonspecific gap junction uncouplers in the lungs of wild-type mice and in lungs from mice lacking Cx40 ([Cx40.sup.-/-]). In vivo, hypoxemia was more severe in [Cx40.sup.-/-] mice than in wild-type mice. Real-time fluorescence imaging revealed that hypoxia caused endothelial membrane depolarization in alveolar capillaries that propagated to upstream arterioles in wild-type, but not [Cx40.sup.-/-], mice. Transformation of endothelial depolarization into vasoconstriction involved endothelial voltage-dependent α1G subtype [Ca.sup.2+] channels, cytosolic phospholipase [A.sub.2], and epoxyeicosatrienoic acids. Based on these data, we propose that HPV originates at the alveolocapillary level, from which the hypoxic signal is propagated as endothelial membrane depolarization to upstream arterioles in a Cx40-dependent manner., Introduction Hypoxic pulmonary vasoconstriction (HPV) is a fundamental physiological mechanism by which the lung optimizes ventilation/perfusion (V/Q) matching, redirecting blood flow from poorly to better ventilated areas (1). Yet in [...]
- Published
- 2012
- Full Text
- View/download PDF
5. A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice
- Author
-
Bernatchez, Pascal, Sharma, Arpeeta, Bauer, Philip M., Marin, Ethan, and Sessa, William C.
- Subjects
Vascular endothelium -- Genetic aspects ,Caveolae -- Properties ,Nitric oxide -- Health aspects ,Blood vessels -- Dilatation ,Health care industry - Abstract
Aberrant regulation of eNOS and associated NO release are directly linked with various vascular diseases. Caveolin-1 (Cav-1), the main coat protein of caveolae, is highly expressed in endothelial cells. Its scaffolding domain serves as an endogenous negative regulator of eNOS function. Structure-function analysis of Cav-1 has shown that phenylalanine 92 (F92) is critical for the inhibitory actions of Cav-1 toward eNOS. Herein, we show that F92A-Cav-1 and a mutant cell-permeable scaffolding domain peptide called Cavnoxin can increase basal NO release in eNOS-expressing cells. Cavnoxin reduced vascular tone ex vivo and lowered blood pressure in normal mice. In contrast, similar experiments performed with eNOS- or Cav-1-deficient mice showed that the vasodilatory effect of Cavnoxin is abolished in the absence of these gene products, which indicates a high level of eNOS/Cav-1 specificity. Mechanistically, biochemical assays indicated that noninhibitory F92A-Cav-1 and Cavnoxin specifically disrupted the inhibitory actions of endogenous Cav-1 toward eNOS and thereby enhanced basal NO release. Collectively, these data raise the possibility of studying the inhibitory influence of Cav-1 on eNOS without interfering with the other actions of endogenous Cav-1. They also suggest a therapeutic application for regulating the eNOS/Cav-1 interaction in diseases characterized by decreased NO release., Introduction NO is well known to actively regulate vascular tone and blood pressure (BP). eNOS is the main source of vascular NO, and aberrant regulation of eNOS activity is linked [...]
- Published
- 2011
- Full Text
- View/download PDF
6. Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries
- Author
-
Burridge, Kelley A. and Friedman, Morton H.
- Subjects
Arteries -- Genetic aspects ,Genetic transcription -- Physiological aspects ,Vascular endothelium -- Genetic aspects ,Physiology, Pathological -- Research ,Epigenetic inheritance -- Research ,Biological sciences - Abstract
Atherosclerotic plaques tend to form in the major arteries at certain predictable locations. As these arteries vary in atherosusceptibility, interarterial differences in endothelial cell biology are of considerable interest. To explore the origin of differences observed between typical atheroprone and atheroresistant arteries, we used DNA microarrays to compare gene expression profiles of harvested porcine coronary (CECs) and iliac artery endothelial cells (IECs) grown in static culture out to passage 4. Fewer differences were observed between the transcriptional profiles of CECs and IECs in culture compared with in vivo, suggesting that most differences observed in vivo were due to distinct environmental cues in the two arteries. One-class significance of microarrays revealed that most in vivo interarterial differences disappeared in culture, as fold differences after passaging were not significant for 85% of genes identified as differentially expressed in vivo at 5% false discovery rate. However, the three homeobox genes, HOXA9, HOXA10, and HOXD3, remained underexpressed in coronary endothelium for all passages by at least nine-, eight-, and twofold, respectively. Continued differential expression, despite removal from the in vivo environment, suggests that primarily heritable or epigenetic mechanism(s) influences transcription of these three genes. Quantitative real-time polymerase chain reaction confirmed expression ratios for seven genes associated with atherogenesis and over- or underexpressed by threefold in CECs relative to IECs. The present study provides evidence that both local environment and vascular bed origin modulate gene expression in arterial endothelium. The transcriptional differences observed here may provide new insights into pathways responsible for coronary artery susceptibility. vascular endothelium; atherosclerosis; pathophysiology; genomics; epigenetics doi: 10.1152/ajpheart.00002.2010.
- Published
- 2010
7. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
- Author
-
Whitehead, Kevin J., Chan, Aubrey C., Navankasattusas, Sutip, Koh, Wonshill, London, Nyall R., Ling, Jing, Mayo, Anne H., Drakos, Stavros G., Marchuk, Douglas A., Davis, George E., and Li, Dean Y.
- Subjects
Arteriovenous malformations -- Risk factors ,Arteriovenous malformations -- Genetic aspects ,Arteriovenous malformations -- Research ,Guanosine triphosphatase -- Physiological aspects ,Guanosine triphosphatase -- Research ,Gene mutations -- Research ,Vascular endothelium -- Genetic aspects ,Vascular endothelium -- Research - Abstract
Cerebral cavernous malformation (CCM) is a common vascular dysplasia that affects both systemic and central nervous system blood vessels. Loss of function mutations in the CCM2 gene cause CCM. Here we show that targeted disruption of Ccm2 in mice results in failed lumen formation and early embryonic death through an endothelial cell autonomous mechanism. We show that CCM2 regulates endothelial cytoskeletal architecture, cell-to-cell interactions and lumen formation. Heterozygosity at Ccm2, a genotype equivalent to that in human CCM, results in impaired endothelial barrier function. On the basis of our biochemical studies indicating that loss of CCM2 results in activation of RHOA GTPase, we rescued the cellular phenotype and barrier function in heterozygous mice with simvastatin, a drug known to inhibit Rho GTPases. These data offer the prospect for pharmacological treatment of a human vascular dysplasia with a widely available and safe drug., ********** Cerebral cavernous malformations are common vascular malformations that affect the systemic and central nervous system (CNS) vasculature with a prevalence of I in 200 to 250 individuals (1,2) in [...]
- Published
- 2009
8. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded [Ab.sub.Ese1] liposomes
- Author
-
Asgeirsdottir, Sigridur A., Zwiers, Peter J., Morselt, Henriettte W., Moorlag, Hendrik E., Bakker, Hester I., Heeringa, Peter, Kok, Jan Willem, Kallenberg, Cees G.M., Molema, Grietje, and Kamps, Jan A.A.M.
- Subjects
Kidney glomerulus -- Genetic aspects ,Gene expression -- Research ,Vascular endothelium -- Genetic aspects ,Liposomes -- Usage ,Glomerulonephritis -- Physiological aspects ,Glomerulonephritis -- Genetic aspects ,Biological sciences - Abstract
E-selectin-directed targeted drug delivery was analyzed in anti-glomerular basement membrane glomerulonephritis. Liposomes conjugated with anti-E-selectin antibodies ([Ab.sub.Ese1] liposomes) were internalized by activated endothelial cells in vitro through E-selectin-mediated endocytosis. At the onset of glomerulonephritis in mice, E-selectin was expressed on glomerular endothelial cells, which resulted in homing of [Ab.sub.Ese1] liposomes to glomeruli after intravenous administration. Accumulation of [Ab.sub.Ese1] liposomes in the kidney was 3.6 times higher than nontargeted IgG liposomes, whereas the accumulation of both liposomes in the clearance organs liver and spleen and in heart and lungs was comparable. In glomeruli, the [Ab.sub.Es1] liposomes colocalized with the endothelial cell marker CD31. Quantitative RT-PCR analysis of laser-microdissected arterioles, glomeruli, and postcapillary venules demonstrated that targeted delivery of dexamethasone by [Ab.sub.Ese1] liposomes reduced glomerular endothelial expression of P-selectin, E-selectin, and vascular cell adhesion molecule-1 by 60-70%. The expression of these genes was not modulated in endothelial cells in nontargeted renal microvasculatures. Decrease of glomerular endothelial activation at disease onset was followed by reduced albuminuria at day 7. This study demonstrates the potential of vascular bed-specific drug delivery aimed at disease-induced epitopes on the microvascular endothelial cells as a therapeutic strategy for glomerulonephritis. glomerular endothelial cells; antiglomerular basement membrane disease; targeted interference: adhesion molecules; vascular gene expression
- Published
- 2008
9. Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension
- Author
-
Mukhopadhyay, Somshuvra, Shah, Mehul, Xu, Fang, Patel, Kirit, Tuder, Rubin M., and Sehgal, Pravin B.
- Subjects
Vascular endothelium -- Genetic aspects ,Biological sciences - Abstract
Lung vascular lesions in pulmonary arterial hypertension (PAH) are characterized by enlarged, vacuolated ('megalocytotic') pulmonary arterial endothelial (PAEC) and smooth muscle cells (PASMC). We have recently proposed that dysfunction of vesicle tethers, soluble N-ethylmaleimide-sensitive factor attachment proteins (SNAPs), and SNAP receptors (SNAREs), leading to disruptions of intracellular trafficking in the Golgi to plasma membrane (centrifugal) and the plasma membrane to cell interior (centripetal) directions is a key causal mechanism in this disease. In PAH, there was a reciprocal relationship between loss of caveolin-1 (car-1) in PAECs and increased expression of 'activated' tyrosine-phosphorylated STAT3 (PY-STAT3) associated with a block in centrifugal trafficking to/through the Golgi organelle. In the present study, we investigated 1) whether centripetal trafficking of STAT3 and PY-STAT3 in PAECs and PASMCs was membrane-associated, and 2) whether this might be affected in PAH. Immunofluorescence and live cell imaging studies showed that, in both PAEC and PASMC, STAT3 was associated with cytoplasmic vesicles partially colocalizing with markers of the endolysosomal compartments (clathrin, EEA1, Rab5, Rab11, and LAMP1). Overexpression of cav-1 increased the targeting of STAT3 to lysosomes and inhibited STAT3 transcriptional activity. Exposure of PAECs to monocrotaline (MCT) pyrrole, which causes PAH in the rat, led to a loss of caveolar STAT3 with increased sequestration of STAT3 and PY-STAT3 in endosomes. In vivo, marked cytoplasmic sequestration of activated PY-STAT3 was a common feature in PAEC in the rat/MCT model and in cells in the proliferative arterial and plexiform lesions in PAH in humans. These data highlight the epigenetic regulation of centripetal cytokine and growth-factor signaling pathways and its modulation in PAH. caveolin- 1; signaling endosome; monocrotaline
- Published
- 2008
10. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure
- Author
-
Sheikh, Ahmad Y., Chun, Hyung J., Glassford, Alexander J., Kundu, Ramendera K., Kutschka, Ingo, Ardigo, Diego, Hendry, Stephen L., Wagner, Roger A., Chen, Mary M., Ali, Ziad A., Yue, Patrick, Huynh, Diem T., Connolly, Andrew J., Pelletier, Marc P., Tsao, Philip S., Robbins, Robert C., and Quertermous, Thomas
- Subjects
Myocardial ischemia -- Development and progression ,Myocardial ischemia -- Physiological aspects ,Myocardial ischemia -- Genetic aspects ,Ligands (Biochemistry) -- Physiological aspects ,Ligands (Biochemistry) -- Genetic aspects ,Muscle contraction -- Properties ,Gene expression -- Evaluation ,Vascular endothelium -- Genetic aspects ,Vascular endothelium -- Chemical properties ,Biological sciences - Abstract
Signaling by the peptide ligand apelin and its cognate G protein-coupled receptor APJ has a potent inotropic effect on cardiac contractility and modulates systemic vascular resistance through nitric oxide-dependent signaling. In addition, there is evidence for counterregulation of the angiotensin and vasopressin pathways. Regulatory stimuli of the apelin-APJ pathway are of obvious importance but remain to be elucidated. To better understand the physiological response of apelin-APJ to disease states such as heart failure and to elucidate the mechanism by which such a response might occur, we have used the routine model of left anterior descending coronary artery ligation-induced ischemic cardiac failure. To identify the key cells responsible for modulation and production of apelin in vivo, we have created a novel apelin-lacZ reporter mouse. Data from these studies demonstrate that apelin and APJ are upregulated in the heart and skeletal muscle following myocardial injury and suggest that apelin expression remains restricted to the endothelium. In cardiac failure, endothelial apelin expression correlates with other hypoxia-responsive genes, and in healthy animals both apelin and APJ are markedly upregulated in various tissues following systemic hypoxic exposure. Experiments with cultured endothelial cells in vitro show apelin mRNA and protein levels to be increased by hypoxia, through a hypoxia-inducible factor-mediated pathway. These studies suggest that apelin-expressing endothelial cells respond to conditions associated with heart failure, possibly including local tissue hypoxia, and modulate apelin-APJ expression to regulate cardiovascular homeostasis. The apelin-APJ pathway may thus provide a mechanism for systemic endothelial monitoring of tissue perfusion and adaptive regulation of cardiovascular function. congestive heart failure; endothelium; gene expression
- Published
- 2008
11. A polymorphism of the endothelial nitric oxide synthase promoter is asociated with an increase in autonomic imbalance in patients with congestive heart failure
- Author
-
Binkley, Philip F., Nunziatta, Enrico, Liu-Stratton, Yiwen, and Cooke, Glen
- Subjects
Vascular endothelium -- Genetic aspects ,Nitric oxide -- Physiological aspects ,Congestive heart failure -- Genetic aspects ,Congestive heart failure -- Patient outcomes ,Health - Published
- 2005
12. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration
- Author
-
Adams, Ralf H., Diella, Francesca, Hennig, Silvia, Helmbacher, Francoise, Deutsch, Urban, and Klein, Rudiger
- Subjects
Vascular endothelium -- Genetic aspects ,Embryology -- Genetic aspects ,Vertebrates -- Research ,Morphogenesis -- Genetic aspects ,Biological sciences - Abstract
Results show that vascular morphogenesis in the vertebrate embryo is mediated by the transmembrane ligand ephrinB2 and its Eph receptor tyrosine kinase. Data indicate that ephrinB carboxy terminus is involved in the embryo morphogenesis.
- Published
- 2001
13. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development
- Author
-
Gale, Nicolas W. and Yancopoulos, George D.
- Subjects
Mice, mutant strains -- Usage ,Growth factors -- Genetic aspects ,Protein tyrosine kinase -- Research ,Vascular endothelium -- Genetic aspects ,Developmental genetics -- Research ,Cardiovascular system -- Genetic aspects ,Cell differentiation -- Genetic aspects ,Biological sciences - Abstract
In vasculogenesis growth factors act via endothelial cell-specific receptor tyrosine kinases. Vascular endothelial growth factors (VEGFs), ephrins and Angiopoietins have roles in vascular development, based on information from studies with knockout mice. The three different growth factor systems act in very different ways. VEGF and Angiopoietins seem to be complementary and coordinated in action. Ephrins seem to be important in later stages, but may be involved in formation of vessel primodia. Complementary expression patterns are important, but overlapping expression of ligands and receptors will likely in time be seen to be mechanistically important. Little is thusfar known about mechanisms of intracellular signaling in endothelial cells and about unique pathways. The available body of knowledge is reviewed.
- Published
- 1999
14. Effects of coronary artery disease on expression and microvascular response to VEGF
- Author
-
Metais, Caroline, Li, Jianyi, Simons, Michael, and Sellke, Frank W.
- Subjects
Vascular endothelium -- Genetic aspects ,Coronary heart disease -- Genetic aspects ,Growth factors -- Genetic aspects ,Microcirculation -- Genetic aspects ,Glycoproteins -- Genetic aspects ,Biological sciences - Abstract
A study was conducted to investigate the effects of coronary artery disease on gene expression of vascular endothelial growth factor (VEGF), the VEGF receptors flk-1 and flt-1, cNOS and inducible nitric oxide synthase in the human heart. The microvascular responses to VEGF and other physiologically significant vasoactive substances were examined to confirm a functional correlate to the possible alterations in expressions. The findings are discussed.
- Published
- 1998
15. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis
- Author
-
Seghezzi, Graziano, Patel, Sundeep, Ren, Christine J., Gualandris, Anna, Pintucci, Giuseppe, Robbins, Edith S., Shapiro, Richard L., Galloway, Aubrey C., Rifkin, Daniel B., and Mignatti, Paolo
- Subjects
Cytochemistry -- Research ,Growth factors -- Physiological aspects ,Vascular endothelium -- Genetic aspects ,Neovascularization -- Genetic aspects ,Autocrine mechanisms -- Physiological aspects ,Cell differentiation -- Physiological aspects ,Capillaries -- Physiological aspects ,Biological sciences - Abstract
Fibroblast growth factor-2 (FGF-2) and its induction of vascular endothelial growth factor (VEGF) expression in endothelial cells of forming capillaries are discussed relative to contributing to angiogenesis through autocrine mechanisms. VEGF is the prototype member of a family of four structurally related growth factors. Potential interactions between the two potent angiogenic factors in these cells was studied.
- Published
- 1998
16. Posttranslation regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells
- Author
-
Parenova, Helena, Balabanova, Liliya, and Leffler, Charles W.
- Subjects
Vascular endothelium -- Genetic aspects ,Phosphorylation -- Analysis ,Tyrosine -- Genetic aspects ,Endothelium -- Cytology ,Swine -- Physiological aspects ,Biological sciences - Abstract
Research was conducted to study the effects of inhibitors on cyclooxygenase (COX) activity in intact ells, COX-1 and COX-2 isoform-specific proteins, and tyrosine-phosphorylated proteins in cell lysates. Brain cortex and aortae were gathered from newborn pigs anesthetized with ketamine acepromazine. Results indicated that arachidonic acid-induced dilation of cerebral arterioles can be utilized as a model of a COX-mediated vascular response in vivo.
- Published
- 1998
17. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice
- Author
-
Schlaeger, Thorsten M., Bartunkova, Sona, Lawitts, Joel A., Teichmann, Gunnar, Risau, Werner, Deutsch, Urban, and Sato, Thomas N.
- Subjects
Genetically modified mice -- Genetic aspects ,Vascular endothelium -- Genetic aspects ,Introns -- Analysis ,Promoters (Genetics) -- Analysis ,Gene expression -- Research ,Science and technology - Abstract
TIE2 is a vascular endothelial-specific receptor tyrosine kinase essential for the regulation of vascular network formation and remodeling. Previously, we have shown that the 1.2-kb 5[prime] flanking region of the TIE2 promoter is capable of directing [Beta]-galactosidase reporter gene expression specifically into a subset of endothelial cells (ECs) of transgenic mouse embryos. However, transgene activity was restricted to early embryonic stages and not detectable in adult mice. Herein we describe the identification and characterization of an autonomous endothelial-specific enhancer in the first intron of the mouse TIE2 gene. Furthermore, combination of the TIE2 promoter with an intron fragment containing this enhancer allows it to target reporter gene expression specifically and uniformly to virtually all vascular ECs throughout embryogenesis and adulthood. To our knowledge, this is the first time that an in vivo expression system has been assembled by which heterologous genes can be targeted exclusively to the ECs of the entire vasculature. This should be a valuable tool to address the function of genes during physiological and pathological processes of vascular ECs in vivo. Furthermore, we were able to identify a short region critical for enhancer function in vivo that contains putative binding sites for Ets-like transcription factors. This should, therefore, allow us to determine the molecular mechanisms underlying the vascular-EC-specific expression of the TIE2 gene.
- Published
- 1997
18. Adenosine stimulation of DNA synthesis in human endothelial cells
- Author
-
Ethier, Michael F. and Dobson, James G., Jr.
- Subjects
Vascular endothelium -- Genetic aspects ,DNA ,Adenosine -- Physiological aspects ,Phospholipases -- Physiological aspects ,Adenosine triphosphate -- Physiological aspects ,Protein kinases -- Physiological aspects ,Biological sciences - Abstract
Human umbilical vein endothelial cells (HUVECs) exposed to adenosine were analyzed after the incorporation of [3H]thymidine to determine the mitogenic effects of the purine nucleoside. Exposure of HUVECs to adenosine increased [3H]thymidine incorporation due to increased rate of DNA synthesis which was attenuated by blocking Na+/H+ exchange and phospholipase A2 activity. Furthermore, adenosine-stimulated DNA synthesis in HUVEC cells was activated by adenosine 3',5'-triphosphate via P2 receptors or phorbol ester activation of protein kinase C.
- Published
- 1997
19. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
- Author
-
Mohle, Robert, Green, David, Moore, Malcolm A.S., Nachman, Ralph L., and Rafii, Shahin
- Subjects
Growth factors -- Genetic aspects ,Cytokines -- Genetic aspects ,Vascular endothelium -- Genetic aspects ,Cell proliferation -- Research ,Science and technology - Abstract
We have shown that coculture of bone marrow microvascular endothelial cells with hematopoietic progenitor cells results in proliferation and differentiation of megakaryocytes. In these long-term cultures, bone marrow microvascular endothelial cell monolayers maintain their cellular integrity in the absence of exogenous endothelial growth factors. Because this interaction may involve paracrine secretion of cytokines, we evaluated megakaryocytic cells for secretion of vascular endothelial growth factor (VEGF). Megakaryocytes ([CD41a.sup.+]) were generated by ex vivo expansion of hematopoietic progenitor cells with kit-ligand and thrombopoietin for 10 days and further purified with immunomagnetic microbeads. Using reverse transcription-PCR, we showed that megakaryocytic cell lines (Dami, HEL) and purified megakaryocytes expressed mRNA of the three VEGF isoforms (121, 165, and 189 amino acids). Large quantities of VEGF (>1 ng/[10.sup.6] cells/3 days) were detected in the supernatant of Dami cells, ex vivo-generated megakaryocytes, and [CD41a.sup.+] cells isolated from bone marrow. The constitutive secretion of VEGF by [CD41a.sup.+] cells was stimulated by growth factors of the megakaryocytic lineage (interleukin 3, thrombopoietin). Western blotting of heparin-Sepharose-enriched supernatant mainly detected the isoform [VEGF.sub.165]. In addition, immunohistochemistry showed intracytoplasmic VEGF in polyploid megakaryocytes. Thrombin stimulation of megakaryocytes and platelets resulted in rapid release of VEGF within 30 min. We conclude that human megakaryocytes produce and secrete VEGF in an inducible manner. Within the bone marrow microenvironment, VEGF secreted by megakaryocytes may contribute to the proliferation of endothelial cells. VEGF delivered to sites of vascular injury by activated platelets may initiate angiogenesis.
- Published
- 1997
20. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats
- Author
-
Noll, Georg, Lang, Marcus G., Tschudi, Marcel R., Ganten, Detlev, and Luscher, Thomas F.
- Subjects
Genetically modified mice -- Physiological aspects ,Vasoconstriction -- Genetic aspects ,Arteries -- Genetic aspects ,Mesentery -- Blood-vessels ,Hypertension -- Genetic aspects ,Angiotensin -- Genetic aspects ,Vascular endothelium -- Genetic aspects ,Biological sciences - Abstract
The endothelium and vascular smooth muscle function of the mesenteric resistance arteries of Ren-2 transgenic and Sprague-Dawley rats were analyzed by myographs. Ren-2 transgenic and control rats exhibited similar response to the vasoconstrictive action of angiotensin I and II. However, the mesenteric arteries of Ren-2 transgenic rats exhibited higher sensitivity to thromboxane while administration of acetylcholine and angiotensin II
- Published
- 1997
21. Identification of the vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress
- Author
-
Topper, James N., Cai, Jiexing, Falb, Dean, and Gimbrone, Michael A., Jr.
- Subjects
Atherosclerosis -- Genetic aspects ,Genetic regulation -- Research ,Vascular endothelium -- Genetic aspects ,Science and technology - Abstract
Early atherosclerotic lesions develop in a topographical pattern that strongly suggests involvement of hemodynamic forces in their pathogenesis. We hypothesized that certain endothelial genes, which exhibit differential responsiveness to distinct fluid mechanical stimuli, may participate in the atherogenic process by modulating, on a local level within the arterial wall, the effects of systemic risk factors. A differential display strategy using cultured human endothelial cells has identified two genes, manganese superoxide dismutase and cyclooxygenase-2, that exhibit selective and sustained up-regulation by steady laminar shear stress (LSS). Turbulent shear stress, a nonlaminar fluid mechanical stimulus, does not induce these genes. The endothelial form of nitric oxide synthase also demonstrates a similar LSS-selective pattern of induction. Thus, three genes with potential atheroprotective (antioxidant, antithrombotic, and antiadhesive) activities manifest a differential response to distinct fluid mechanical stimuli, providing a possible mechanistic link between endothelial gene expression and early events in atherogenesis. The activities of these and other LSS-responsive genes may have important implications for the pathogenesis and prevention of atherosclerosis.
- Published
- 1996
22. Hypoxia enhances stimulus-dependent induction of E-selectin on aortic endothelial cells
- Author
-
Zund, Gregor, Nelson, David P., Neufeld, Ellis J., Dzus, Andrea L., Bischoff, Joyce, Mayer, John E., and Colgan, Sean P.
- Subjects
Vascular endothelium -- Genetic aspects ,Hypoxia -- Genetic aspects ,Leukocytes -- Genetic aspects ,Science and technology - Abstract
In many diseases, tissue hypoxia occurs in conjunction with other inflammatory processes. Since previous studies have demonstrated a role for leukocytes in ischemia/reperfusion injury, we hypothesized that endothelial hypoxia may 'superinduce' expression of an important leukocyte adhesion molecule, E-selectin (ELAM-1, CD62E). Bovine aortic endothelial monolayers were exposed to hypoxia in the presence or absence of tumor-necrosis factor [Alpha] (TNF-[Alpha]) or lipopolysaccharide (LPS). Cell surface E-selectin was quantitated by whole cell ELISA or by immunoprecipitation using polyclonal anti-E-selectin sera. Endothelial mRNA levels were assessed using ribonuclease protection assays. Hypoxia alone did not induce endothelial E-selectin expression. However, enhanced induction of E-selectin was observed with the combination of hypoxia and TNF-[Alpha] (270% increase over normoxia and TNF-[Alpha]) or hypoxia and LPS (190% increase over normoxia and LPS). These studies revealed that a mechanism for such enhancement may be hypoxia-elicited decrements in endothelial intracellular levels of cAMP (
- Published
- 1996
23. Platelet-derived growth factor B chain promotor contains a cis-acting fluid shear-stress-responsive element
- Author
-
Resnick, Nitzan, Collins, Tucker, Atkinson, William, Bonthron, David T., Dewey, C. Forbes, Jr., and Gimbrone, Michael A., Jr.
- Subjects
Genetic regulation -- Research ,Platelet activating factor -- Usage ,Vascular endothelium -- Genetic aspects ,Science and technology - Abstract
The description of the direct relationship between shear stress and vascular endothelial cell gene transcription by an in vitro mechanical system and the B chain of platelet-derived growth factor (PGGF-B) is discussed. The operation of a series of mutant PDGF-B promoter-chloramphenicol acetyltransferase reporter gene constructs transfected into cultured bovine aortic endothelial cells were subjected to Northern blot analysis. The regulation of vascular endothelium by shear-stress-induced transcription factors was demonstrated.
- Published
- 1993
24. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium
- Author
-
Uyttendaele, H., Ho, J., Rossant, J., and Kitajewski, J.
- Subjects
Vascular endothelium -- Genetic aspects ,Vascular endothelial growth factor -- Physiological aspects ,Gene expression -- Research ,Science and technology - Abstract
Notch proteins function as receptors for membrane-bound ligands (Jagged and Delta-like) to regulate cell-fate determination. We have investigated the role of Notch signaling in embryonic endothelium of the mouse by expressing an activated form of the Notch4 protein in vasculature under the regulation of the Flk1 (VEGFR) locus. Expression of activated Notch4 results in a growth and developmental delay and embryonic lethality at about 10 days postcoitum. The extent of the developing vasculature in mutant embryos was restricted, fewer small vessels were seen, and vascular networks were disorganized. The brain periphery of mutant embryos contained large dilated vessels with evidence of compromised vessel-wall integrity and large areas of necrosis; yolk-sac vasculature was abnormal. Expression of an activated form of Notch4 in embryonic vasculature leads to abnormal vessel structure and patterning, implicating the Notch pathway in phases of vascular development associated with vessel patterning and remodeling. Notch | Flk1 | Jagged1 | vasculature
- Published
- 2001
25. Expression of EphrinB2 Identifies a Stable Genetic Difference Between Arterial and Venous Vascular Smooth Muscle as Well as Endothelial Cells, and Marks Subsets of Microvessels at Sites of Adult Neovascularization
- Author
-
Shin, Donghun, Garcia-Cardena, Guillermo, Hayashi, Shin-Ichiro, Gerety, Sebastian, Asahara, Takayuki, Stavrakis, George, Isner, Jeffrey, Folkman, M. Judah, Gimbrone, Michael A. Jr., and Anderson, David J.
- Subjects
Neovascularization -- Genetic aspects ,Vascular endothelium -- Genetic aspects ,Ligands (Biochemistry) -- Analysis ,Biological sciences - Abstract
The transmembrane ligand ephrinB2 and its receptor tyrosine kinase EphB4 are molecular markers of embryonic arterial and venous endothelial cells, respectively, and are essential for angiogenesis. Here we show that expression of ephrinB2 persists in adult arteries where it extends into some of the smallest diameter microvessels, challenging the classical view that capillaries have neither arterial nor venous identity. EphrinB2 also identifies arterial microvessels in several settings of adult neovascularization, including tumor angiogenesis, contravening the dogma that tumor vessels arise exclusively from postcapillary venules. Unexpectedly, expression of ephrinB2 also defines a stable genetic difference between arterial and venous vascular smooth muscle cells. These observations argue for revisions of classical concepts of capillary identity and the topography of neovascularization. They also imply that ephrinB2 may be functionally important in neovascularization and in arterial smooth muscle, as well as in embryonic angiogenesis.
- Published
- 2001
26. Notch signaling is required for ephrinB2 expression and proper vascular development
- Author
-
Lawson, N. D., Kim, C.-H., Chitnis, A., and Weinstein, B. M.
- Subjects
Cellular signal transduction -- Analysis ,Gene expression -- Analysis ,Vascular endothelium -- Genetic aspects ,Zebra fish -- Research ,Biological sciences - Abstract
Although a few artery and venous specific genes have been uncovered, the factors that determine arterial-venous identity in the vertebrate vasculature are still largely unknown. EphrinB2 and its receptor, EphB4, are expressed on arterial and venous endothelial cells, respectively, and both are required for proper blood vessel development. In zebrafish, ephrinB2 is expressed specifically in the dorsal aorta (DA) beginning at about the 18 somite stage, while the EphB4 paralog rtk5 is expressed in the posterior cardinal vein (PCV). Here, we show that a member of the Notch family of receptors is also expressed specifically in the DA, but not in the PCV, beginning at the 15 to 18 somite stage. We examined the role of Notch in arterial specification using the zebrafish mutant mindbomb (mib), which is defective in Notch signaling. The pan-endothelial marker flk-1 is expressed in two distinct cellular cords corresponding to the DA and PCV in the trunks of both WT and mib embryos. Furthermore, the artery-specific marker tbxH15 is also expressed normally in mib embryos. However, in severe alleles of mib, embryos do not express ephrinB2 in the DA, and the apparent arterial cord of endothelial cells misexpresses rtk5. Other, non-autonomous factors involved in vascular development, such as VEGF, are expressed normally in mib embryos. These results suggest that signaling by Notch is important for inducing ephrinB2 expression in the dorsal aorta and for subsequent vascular morphogenesis, although at least some aspects of dorsal aorta specification take place in the absence of Notch signaling.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.